Underutilization of the current clinical capacity to provide buprenorphine treatment for opioid use disorders within the Veterans Health Administration

2018 ◽  
Vol 39 (3) ◽  
pp. 286-288 ◽  
Author(s):  
Helen Valenstein-Mah ◽  
Hildi Hagedorn ◽  
Chad L. Kay ◽  
Melissa L. Christopher ◽  
Adam J. Gordon
2019 ◽  
Vol 50 (12) ◽  
pp. 2107-2112 ◽  
Author(s):  
Lisham Ashrafioun ◽  
Kotwoallama R. A. Zerbo ◽  
Todd M. Bishop ◽  
Peter C. Britton

AbstractBackgroundThe purpose of this study was to assess the associations of comorbid opioid use disorders and psychiatric disorders with suicide attempts among veterans seeking pain care.MethodsThe cohort (N = 226 444) was selected by identifying pain care initiation from 2012 to 2014 using national Veterans Health Administration (VHA) data. Data on opioid use disorders (OUD), psychiatric disorders, medical comorbidity, demographics at baseline, and suicide attempts in the year following the initiation of pain care were extracted from VHA databases. Relative excess risk due to interaction (RERI) was used to assess departure from additivity of effects.ResultsAdjusted models indicated that both comorbid OUD and depression (RERI = 1.07) and comorbid OUD and AUD (RERI = 1.23) were significantly associated with additive risk of suicide attempt. In adjusted multiplicative interaction models, only comorbid OUD and bipolar disorder was significantly associated with suicide attempts; however, this association was protective (HR = 0.54).ConclusionsThe current findings highlight the importance of addressing opioid use disorders and alcohol use disorders and depression together to mitigate the risk of suicidal behavior.


2021 ◽  
pp. 1-11
Author(s):  
MacKenzie R. Peltier ◽  
Mehmet Sofuoglu ◽  
Ismene L. Petrakis ◽  
Elina Stefanovics ◽  
Robert A. Rosenheck

Pain Medicine ◽  
2019 ◽  
Vol 21 (3) ◽  
pp. 595-603 ◽  
Author(s):  
Seshadri C Mudumbai ◽  
Paul Chung ◽  
Nick Nguyen ◽  
Brooke Harris ◽  
J David Clark ◽  
...  

Abstract Objective Among Veterans Health Administration (VHA) patients who undergo total knee arthroplasty (TKA) nationally, what are the underlying readmission rates and associations with perioperative opioid use, and are there associations with other factors such as preoperative health care utilization? Methods We retrospectively examined the records of 5,514 TKA patients (primary N = 4,955, 89.9%; revision N = 559, 10.1%) over one fiscal year (October 1, 2010–September 30, 2011) across VHA hospitals nationwide. Opioid use was classified into no opioids, tramadol only, short-acting only, or any long-acting. We measured readmission within 30 days and the number of days to readmission within 30 days. Extended Cox regression models were developed. Results The overall 30-day hospital readmission rate was 9.6% (N = 531; primary 9.5%, revision 11.1%). Both readmitted patients and the overall sample were similar on types of preoperative opioid use. Relative to patients without opioids, patients in the short-acting opioids only tier had the highest risk for 30-day hospital readmission (hazard ratio = 1.38, 95% confidence interval = 1.14–1.67). Preoperative opioid status was not associated with 30-day readmission. Other risk factors for 30-day readmission included older age (≥66 years), higher comorbidity and diagnosis-related group weights, greater preoperative health care utilization, an urban location, and use of preoperative anticonvulsants. Conclusions Given the current opioid epidemic, the routine prescribing of short-acting opioids after surgery should be carefully considered to avoid increasing risks of 30-day hospital readmissions and other negative outcomes, particularly in the context of other predisposing factors.


JAMA Surgery ◽  
2019 ◽  
Vol 154 (12) ◽  
pp. 1158
Author(s):  
Karthik Raghunathan ◽  
Neil Ray ◽  
William Bryan ◽  
Marc Pepin ◽  
Robert Overman ◽  
...  

2018 ◽  
Vol 14 (3) ◽  
pp. 171-182 ◽  
Author(s):  
Theddeus Iheanacho, MD ◽  
Elina Stefanovics, PhD ◽  
Robert Rosenheck, MD

Objective: The aim of this study is to estimate the prevalence and sociodemographic and clinical correlates of opioid use disorder (OUD), a major cause of morbidity and mortality in the United States, among homeless veterans nationally in the Veterans Health Administration (VHA).Design: Administrative data on 256,404 veterans who were homeless and/or had OUD in fiscal year 2012 were analyzed to evaluate OUD as a risk factor for homelessness along with associated characteristics, comorbidities, and patterns of service use. Bivariate analyses and logistic regression were used to compare homeless veterans with OUD to veterans with OUD but no homelessness and homeless veterans with no OUD.Results: Altogether 17.9 percent of homeless VHA users were diagnosed with OUD and 34.6 percent of veterans with OUD were homeless. The risk ratio (RR) for homelessness among veterans with OUD was 28.7. Homeless veterans with OUD, compared to nonhomeless veterans with OUD showed extensive multimorbidity with greater risk for HIV (RR = 1.57), schizophrenia (RR = 1.62), alcohol use disorder (RR = 1.67), and others. Homeless veterans with OUD also showed more multimorbidity and used more services than homeless veterans without OUD. Homeless and nonhomeless OUD veterans used opiate agonist therapy at similar, but very low rates (13 and 15 percent).Conclusions: OUD is a major risk factor for homelessness. Homeless veterans with OUD have high levels of multimorbidity and greater service use than veterans with either condition alone. Tailored, facilitated access to opioid agonist therapy may improve outcomes for these vulnerable veterans.


2020 ◽  
Vol Publish Ahead of Print ◽  
Author(s):  
Andrea K. Finlay ◽  
Alex H. S. Harris ◽  
Christine Timko ◽  
Mengfei Yu ◽  
David Smelson ◽  
...  

2008 ◽  
Vol 17 (6) ◽  
pp. 459-462 ◽  
Author(s):  
Adam J. Gordon ◽  
Joseph Liberto ◽  
Stephanie Granda ◽  
Sara Salmon-Cox ◽  
Tykia Andrée ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document